60 DEGREES PHARMACEUTICALS, INC. - 10-Q Filing
60 Degrees Pharmaceuticals reports Q3 2026 financial results including updates on warrants, preferred stock, and contingent milestone payments.
Tickers: $SXTP
60 Degrees Pharmaceuticals reports Q3 2026 financial results including updates on warrants, preferred stock, and contingent milestone payments.
Tickers: $SXTP